Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vatalanib in Metastatic Cutaneous Melanoma
NCT00563823Phase 2Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Feb 2006
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of vatalanib in cutaneous melanoma (CM), sponsored by Cambridge University Hospitals NHS Foundation Trust. Primary endpoint: Response Rate. Started Feb 2006; status: completed.
02
Drugs
vatalanib
03
Conditions
cutaneous melanoma (CM)
Beyond the preview
Go deeper on NCT00563823.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00563823.